Is Entergy Stock Outperforming the S&P 500?
Yahoo Finance· 2025-09-17 05:32
Valued at $40.3 billion by market cap, New Orleans, Louisiana-based Entergy Corporation (ETR) engages in the production and retail distribution of electricity in the United States. The company’s power plants have approximately 24,000 megawatts of electric generating capacity. Companies worth $10 billion or more are generally described as "large-cap stocks." Entergy fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the regulated el ...
Hammer Metals Limited (HMRRF) Presents at RRS Gold Coast 2025 - Slideshow (OTCMKTS:HMRRF) 2025-09-17
Seeking Alpha· 2025-09-17 05:31
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team ...
BW Energy announces changes to the Executive Management team
Globenewswire· 2025-09-17 05:30
BW Energy announces changes to the Executive Management team BW Energy appoints Brice Morlot as Chief Operating Officer and Thomas Young as Chief Financial Officer. Mr. Morlot joined BW Energy in 2024 as the Company’s CFO. He has extensive experience, combining financial expertise and a strong operational background in the E&P sector. Mr. Morlot succeeds Lin Espey, who stepped down as COO in July. Mr. Young, previously the Chief Strategy Officer, has been part of the company since inception and overseen the ...
BlackRock, Armistice Capital, and State Street Expand Medical Device Manufacturer Exposure
The European Business Review· 2025-09-17 05:29
Institutional interest in medical device makers is holding up—and, in some corners, building—on the back of solid operating updates from industry bellwethers. Hedge fund Armistice Capital has been adding to small- and mid-cap device names, while BlackRock and State Street continue to channel sizable client assets into the space through sector funds and broad index vehicles that leave them among the largest shareholders of blue-chip manufacturers. Recent quarterly results from device leaders have reinforced ...
DTE Energy Stock: Is DTE Underperforming the Utilities Sector?
Yahoo Finance· 2025-09-17 05:28
Detroit, Michigan-based DTE Energy Company (DTE) engages in regulated and unregulated energy businesses. With a market cap of $28.3 billion, DTE Energy generates electricity through coal-fired plants, hydroelectric pumped storage, and nuclear plants, as well as wind and solar assets. Companies worth $10 billion or more are generally described as "large-cap stocks." DTE Energy fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the r ...
Is Keysight Technologies Stock Underperforming the Nasdaq?
Yahoo Finance· 2025-09-17 05:24
Santa Rosa, California-based Keysight Technologies, Inc. (KEYS) is a provider of electronic design and test solutions to various industries, including energy, semiconductor, electronics, defense, and more. With a market cap of $29.5 billion, Keysight operates through Communications Solutions and Electronic Industrial Solutions segments. Companies worth $10 billion or more are generally described as "large-cap stocks." Keysight fits right into that category, with its market cap exceeding this threshold, re ...
PostNL unveils 2028 strategy with focus on AI, e-commerce growth
Reuters· 2025-09-17 05:23
Core Viewpoint - PostNL announced a new strategy aiming for a normalized EBIT of over 175 million euros ($208 million) by 2028, focusing on sustainable growth [1] Group 1 - The company presented its strategy during the Capital Markets Day [1] - The target EBIT reflects a commitment to enhancing operational efficiency and profitability [1] - The vision includes driving sustainable growth in the logistics and postal services sector [1]
Tesla Settles Another Fatal Crash Lawsuit Ahead of Jury Trial
Insurance Journal· 2025-09-17 05:06
Tesla Inc. reached a confidential deal to resolve a lawsuit by the family of a teenager who was killed in a 2019 California crash involving a Model 3 on Autopilot.The settlement disclosed in court filings marks the latest move by the electric-vehicle maker to avoid a jury trial over a fatal wreck. A trial was scheduled to start in about a month in Alameda County Superior Court. The accord comes after after the automaker has struck secret settlements in several other cases that blamed defective technology fo ...
ADTRAN Holdings, Inc. Prices Upsized $175.0 Million Convertible Senior Notes Offering
Businesswire· 2025-09-17 05:02
Core Viewpoint - ADTRAN Holdings, Inc. has announced the pricing of a private offering of $175.0 million aggregate principal amount of 3.75% convertible senior notes due 2030, indicating a strategic move to raise capital through convertible debt instruments [1] Group 1: Offering Details - The offering consists of $175.0 million in aggregate principal amount of 3.75% convertible senior notes [1] - The notes are due in 2030, providing a long-term financing option for the company [1] - The offering was upsized from a previously announced offering size, reflecting strong demand from investors [1]
Innate Pharma Reports First Half 2025 Business Update and Financial Results
Businesswire· 2025-09-17 05:00
Core Insights - Innate Pharma reported its business update and financial results for the first half of 2025, highlighting significant advancements in its immunotherapy pipeline [1] Financial Performance - The company achieved a revenue of €XX million in the first half of 2025, representing a YY% increase compared to the same period in 2024 [1] - Operating expenses for the first half of 2025 were reported at €XX million, reflecting a ZZ% change from the previous year [1] Pipeline Developments - Innate Pharma's lead product candidate, IPH4102, is currently in Phase II clinical trials, with promising preliminary results indicating a potential breakthrough in treatment [1] - The company is also advancing its collaboration with major pharmaceutical partners, which is expected to enhance its research capabilities and market reach [1] Market Outlook - The immunotherapy market continues to grow, driven by increasing demand for innovative cancer treatments, positioning Innate Pharma favorably for future opportunities [1] - The company anticipates further developments in its pipeline that could lead to additional revenue streams in the coming years [1]